CVS Hit One Out of the Park, Here's My Plan

I like the name, and I like the progress that CVS is making. This stock can go higher.

CVS Health Continues to Improve With Stronger Charts and Fundamentals, Too

Even before reporting better-than-expected third-quarter results, the pharmacy giant was seeing more aggressive buying of its shares.

NovoCure Looks Ready to Resume Its Strong Uptrend After a Correction

Let's review the charts and indicators of NVCR.

Drug Companies Are a Political Football, Trading Amgen: Market Recon

The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.

It's Settled: CVS Health Is Headed Up to $80

Charts and indicators agree with Jim Cramer's bullish year-end call.

Baxter International's Prognosis Looks Poor, Consider Selling

BAX saw shares plunge 10% last week on news of accounting irregularities and the charts appear bearish.

Zebra Technologies Technical Stripes Are Still Bullish After This Latest Rally

Let's review the charts once again.

Fitbit Shares Shape Up on Reports of Offer From Alphabet

The maker of wearable fitness devices has seen its stock sprint higher on the buyout news after languishing this summer near multi-year lows.

2 Small Biotech Stocks Spurt Ahead on Positive Developments

Heron Therapeutics and TG Therapeutics each gave investors reasons for cheer in the last few days.

2 Stocks That Should Benefit From Low Expectations

TherapeuticsMD and Thor Industries are in wholly unrelated sectors, but both stocks look undervalued over the long term.